GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,128.00
Bid: 1,132.00
Ask: 1,136.00
Change: -4.00 (-0.35%)
Spread: 4.00 (0.353%)
Open: 1,130.00
High: 1,150.00
Low: 1,128.00
Prev. Close: 1,132.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update and Acquisitions

25 Jul 2011 07:00

RNS Number : 9327K
CVS Group plc
25 July 2011
 



Immediate Release

25 July 2011

 

 

CVS Group plc

 

Trading update and Acquisitions

 

The Board is pleased to announce that it expects results for the year ended 30 June 2011 to be in line with market expectations. Like for like turnover for the year showed growth in the region of +0.4%, with the second half delivering like for like sales growth in the region of +3%.

 

The Board is also pleased to report further acquisition activity in the second half of the financial year, with RH Campbell, Attimore and Clarendon House veterinary clinics being added to the Group's practice division. Net debt at 30 June was in line with market expectations, being in the region of £34 million, after having funded these acquisitions.

 

RH Campbell is a single site practice in Swansea acquired in January 2011. The turnover of the practice for the year ended 30 November 2010 was in the region of £0.3 million.

 

Attimore Veterinary Group is a five site practice in and around the Welwyn Garden City area acquired in April 2011. The turnover of the practice for the year ended 30 November 2010 was in the region of £1.3 million.

 

Clarendon House Veterinary Group is a three site practice in and around the Chelmsford area acquired in May 2011. The turnover of the practice for the year ended 30 September 2010 was in the region of £1.1 million.

 

All three acquisitions provide a good geographical fit with the Group's existing surgery locations.

 

In total the Group now operates 223 surgeries, 6 diagnostic laboratories, 1 pet crematorium and an online dispensary across the UK and remains the largest operator in a highly fragmented market.

 

The Board of Directors confirms that the preliminary results for the year ended 30 June 2011 will be announced on Tuesday 27 September 2011.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Paul Coxon - Finance Director

 

Buchanan Communications: 020 7466 5000

Richard Oldworth

Christian Goodbody

 

Brewin Dolphin Investment Banking: 0845 059 6412

Nick Owen

Matt Davis

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFEDEIFFIL
Date   Source Headline
26th Jan 20237:00 amRNSHalf year Trading Update
11th Jan 20234:31 pmRNSBlock Listing Interim Review and TVR Update
10th Jan 202312:24 pmRNSExercise of SAYE Options and PDMR Dealing
30th Dec 20227:00 amRNSExercise of Options and Total Voting Rights
20th Dec 20224:38 pmRNSExercise of Options and PDMR Dealing
30th Nov 20227:00 amRNSExercise of Options and Total Voting Rights
25th Nov 20224:22 pmRNSSAYE Option Scheme & PDMR Dealing
23rd Nov 20222:31 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Statement and Trading Update
8th Nov 20227:00 amRNSCapital Markets Day
31st Oct 20227:00 amRNSExercise of Options and Total Voting Rights
28th Oct 202210:22 amRNSAnnual Report, Notice of AGM & Dividend Timetable
12th Oct 202210:52 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:19 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
30th Sep 20227:00 amRNSExercise of Options and Total Voting Rights
29th Sep 202210:34 amRNSHolding(s) in Company
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20224:19 pmRNSDirector/PDMR Shareholding
26th Sep 202211:56 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSFinal Results for the year ended 30 June 2022
31st Aug 20227:00 amRNSExercise of Options and Total Voting Rights
9th Aug 20229:30 amRNSHolding(s) in Company
29th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSAppointment of Nominated Advisor and Joint Brokers
12th Jul 20227:00 amRNSBlock Listing Interim Review and TVR Update
1st Jul 20227:00 amRNSConclusion of CMA process, acquisition and trading
30th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jun 20223:00 pmRNSPostponement to Capital Markets Day
8th Jun 20221:54 pmRNSHolding(s) in Company
31st May 20227:00 amRNSExercise of Options and Total Voting Rights
6th May 20227:00 amRNSAcquisition of Anton Vets
29th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
28th Mar 202210:47 amRNSHolding(s) in Company
24th Mar 20222:54 pmRNSDirector/PDMR Shareholding
24th Mar 202210:03 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInterim Results
21st Mar 20229:14 amRNSHolding(s) in Company
18th Mar 202210:17 amRNSHolding(s) in Company
3rd Mar 20228:38 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSExercise of Options and Total Voting Rights
21st Feb 20225:37 pmRNSHolding(s) in Company
18th Feb 20227:15 amRNSCMA Update
3rd Feb 20229:43 amRNSHolding(s) in Company
31st Jan 20227:00 amRNSExercise of Options and Total Voting Rights
27th Jan 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.